We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+10.41%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$464M
AUM Growth
-$205M
Cap. Flow
-$214M
Cap. Flow %
-45.98%
Top 10 Hldgs %
49.13%
Holding
326
New
128
Increased
6
Reduced
7
Closed
153

Sector Composition

Rank Sector Weight
1 Healthcare 19.42%
2 Financials 8.54%
3 Technology 7.51%
4 Consumer Discretionary 7.04%
5 Industrials 5.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FUSN
276
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-50,000
Closed -$874K
SWAV
277
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
-15,000
Closed -$711K
MRNS
278
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
-200,625
Closed -$2.04M
GMDA
279
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
-149,459
Closed -$683K
SRC
280
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
-100,000
Closed -$3.49M
AMTI
281
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
-70,000
Closed -$1.76M
LVOXW
282
DELISTED
LiveVox Holding, Inc. Warrant
LVOXW
-73,943
Closed -$111K
KLR
283
DELISTED
Kaleyra, Inc.
KLR
-45,714
Closed -$646K
AXLA
284
DELISTED
Axcella Health Inc. Common Stock
AXLA
-9,000
Closed -$1.24M
BKI
285
DELISTED
Black Knight, Inc. Common Stock
BKI
-40,000
Closed -$2.9M
IRNT
286
DELISTED
IronNet, Inc.
IRNT
-67,968
Closed -$674K
ISEE
287
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
-150,000
Closed -$765K
PRVB
288
DELISTED
Provention Bio, Inc. Common Stock
PRVB
-250,000
Closed -$3.53M
CSII
289
DELISTED
Cardiovascular Systems, Inc.
CSII
-250,000
Closed -$7.89M
SFT
290
DELISTED
Shift Technologies, Inc. Class A Common Stock
SFT
-3,500
Closed -$454K
ONEM
291
DELISTED
1Life Healthcare
ONEM
-100,000
Closed -$3.63M
AKUS
292
DELISTED
Akouos Inc
AKUS
-35,000
Closed -$788K
RCOR
293
DELISTED
Renovacor, Inc.
RCOR
-150,000
Closed -$1.49M
CCXI
294
DELISTED
ChemoCentryx, Inc.
CCXI
-100,000
Closed -$5.75M
TPTX
295
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
-55,000
Closed -$3.55M
KLDO
296
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
-150,000
Closed -$1.11M
ARNA
297
DELISTED
Arena Pharmaceuticals Inc
ARNA
-110,000
Closed -$6.92M
SCVX.WS
298
DELISTED
SCVX Corp.
SCVX.WS
-50,000
Closed -$52K
TREB.U
299
DELISTED
Trebia Acquisition Corp. Units, each consisting of one Class A Ordinary Share, and one-third of one
TREB.U
-500,000
Closed -$5.22M
SOLY
300
DELISTED
Soliton, Inc.
SOLY
-300,000
Closed -$2.33M

Similar funds

Monashee Investment Management's Q3 2020 Portfolio in Review

As of Q3 2020, Monashee Investment Management held 326 positions worth $464M, down 31% from $669M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Monashee Investment Management withdrew a net $214M in Q3 2020, closing 153 positions and reducing 7 holdings. Its most notable exit was Nikola Corporation Common Stock, an estimated $67.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 32% a quarter earlier, followed by Financials and Technology.

Against the trend, Monashee Investment Management opened a new position in Vanguard Morningstar Total Stock Market ETF worth $159M.

  • Monashee Investment Management's largest Q3 2020 buy was Vanguard Morningstar Total Stock Market ETF: 935,000 shares worth $159M.
  • Monashee Investment Management added most to Caesars Entertainment in Q3 2020, an estimated $8.13M increase.
  • Monashee Investment Management's biggest Q3 2020 reduction was Firy Inc, cutting an estimated $4.02M.
  • Monashee Investment Management fully exited Nikola Corporation Common Stock in Q3 2020, selling an estimated $67.5M.
  • Monashee Investment Management's ten largest holdings make up 49% of its $464M portfolio in Q3 2020.
  • Monashee Investment Management opened 128 new positions and closed 153 in Q3 2020.
  • Monashee Investment Management's portfolio value fell 31% quarter-over-quarter to $464M.

Based on Monashee Investment Management's 13F filing for Q3 2020, filed 13 Nov 2020.